Fundraising Fox

Biotech Investors & VC Firms in North America

272 firms in this list, with a median first check of $500K. 65 of them lead rounds. Generated from verified public data and updated continuously.

Summit Partners
BostonSeries B–Late Stage$10M – $500M
1 person
Artesian
AustraliaPre-Seed–Late Stage
42 people
Mission Biocapital
San FranciscoPre-Seed–Series A$500K – $500K
20 people
Abingworth
LondonPre-Seed–Late Stage$15M – $30M
39 people
Jeito Capital
Paris
34 people
GroveStreet
NewtonSeries A–Late Stage
39 people
McWin Capital Partners
LondonSeries B–Late Stage
31 people
Blue Revolution Investments G.P.
BergenPre-Seed–Series A
30 people
ZAKA VC
San FranciscoPre-Seed–Series A
Claret Capital Partners
LondonSeries A–Late Stage
28 people
Next Level Ventures
Des MoinesSeed–Late Stage$500K – $5M
16 people
SPRINGROCK VENTURES
SeattleSeed–Late Stage$2M – $5M
14 people
Hoxton Ventures
LondonPre-Seed–Series B$500K – $5M
13 people
Faber
LisbonPre-Seed–Series A$2.7M
17 people
Lumira Ventures
TorontoPre-Seed–Late Stage$1M – $10M
17 people
Novartis Venture Fund
BaselPre-Seed–Late Stage$5M – $25M
22 people
SeaX Ventures
MillbraePre-Seed–Series A$100K – $5M
31 people
Sanderling Ventures
San MateoSeed–Late Stage$50K – $1M
9 people
Broadview Ventures
BostonSeed–Late Stage
20 people
First Analysis
ChicagoSeries A–Late Stage
23 people
TCG Crossover
Palo AltoSeed–Late Stage
25 people
Innovobot
MontrealPre-Seed–Series A$182.5K – $365K
30 people
Arkin Capital
HerzliyaSeed–Late Stage
28 people
WI Harper Group
San FranciscoSeed–Series C$5M – $15M
20 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.